Skip to main content
TipRanks
Go Ultimate75% OFF

Keith Brownlie Insider Profile

4 Followers

Keith Brownlie, Director at Celldex, holds 20.00K shares in Phio Pharmaceuticals (Ticker: PHIO), holds ― shares in Celldex (Ticker: CLDX), holds 50.00K shares in Soligenix (Ticker: SNGX).

Keith Brownlie's Trading History

PHIO
Phio Pharmaceuticals
Feb 15, 2019DirectorUninformative Buy―$15.42K
CLDX
Celldex
Jun 16, 2017DirectorUninformative Buy――
SNGX
Soligenix
Apr 09, 2015DirectorInformative Buy8.71K$16.05K
VYNT
Vyant Bio
May 27, 2014―Uninformative Buy―$970.00
IMNPQ
Immune Pharmaceuticals
Aug 14, 2013―Uninformative Buy―$3.60K

You May Also Like

Keith Brownlie insider profile FAQ

What is the percentage of profitable transactions made by Keith Brownlie?
The percentage of profitable transactions made by Keith Brownlie is 0%.
What is the average return per transaction made by Keith Brownlie?
The average return per transaction made by Keith Brownlie is -36.60%.
What stocks does Keith Brownlie hold?
Keith Brownlie holds: CLDX, SNGX, PHIO, IMNPQ, VYNT stocks.
What was Keith Brownlie's most profitable transaction?
Keith Brownlie’s most profitable transaction was an Informative Buy of SNGX stock on May 16, 2014. The return on the trade was -26.00%.
What is Keith Brownlie's role in Celldex?
Keith Brownlie's role in Celldex is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.